From Nanotechnology to Nanomedicine: Applications to Cancer Research
Keywords: Anthracyclins; Antibodies; Antibody; Antigen; Aptamers; Aptasensors; Biomarkers; Biomolecules; Biosensors; Blood-brain barrier; CTC chip; Camptothecin; Cardiotoxicity; Chemotherapy; Clonogenic cancer cells; DNA topoisomerase; Docetaxel; Doxorubicin; Drug delivery; ELISA; EPR effect; Electrophoresis; Ellipsometry; Enzymes; EpCAM(CD326); Epithelial Cell Adhesion Molecule; Factor alpha; Fluorescence microscope; Immune system; Labs-on-chip; Metastases; Microfluidics; Microtechnologies; Myelosuppression; Nano-objects; Nanomedicine; Nanoparticle; Nanoparticles; Nanorods; Nanospheres; Nanotechnology; Nanotubes; Nanovectorization; Nanowires; Paclitaxel; Pharmacokinetics; Point-of-care devices; Radiotherapy; Reactive oxygen species; Reticuloendothelial system; SPR imaging; Surface plasmon resonance; Tumor necrosis; Vectorization; XMT-1001; circulating tumour cell; immunohistochemistry; nanoparticle
Document Type: Research Article
Publication date: 01 October 2010
- Current Molecular Medicine is an interdisciplinary journal focused on providing the readership with current and comprehensive reviews on fundamental molecular mechanisms of disease pathogenesis, the development of molecular-diagnosis and/or novel approaches to rational treatment. The reviews should be of significant interest to basic researchers and clinical investigators in molecular medicine. Periodically the journal will invite guest editors to devote an issue on a basic research area that shows promise to advance our understanding of the molecular mechanism(s) of a disease or has potential for clinical applications.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content